Business ❯ Pharmaceutical Industry ❯ Drug Development

Market Trends

Novo Nordisk Eli Lilly Consumer Demand Pricing Strategies Stock Performance Consumer Behavior Healthcare Costs GLP-1 Market Insurance Coverage GLP-1 Agonists Eli Lilly & Co. Generic Drugs Biotech Companies Obesity Drug Market Healthcare Funding Counterfeit Drugs Veterinary Pharmaceuticals Consumer Health Products

Peptide Craze Grows as HHS Chief Backs Wider Access

A fast-rising wellness trend centers on lab-made protein fragments that span strict drug rules and looser supplement oversight.

Medicare GLP-1 Use Surges as CMS Advances Coverage Expansion and Lilly Eyes Q2 Pill Launch

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

Eli Lilly Unveils $3 Billion Netherlands Plant for Oral GLP-1 Medicines as Stock Rises

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide